A systematic review of molecular and biological tumor markers in neuroblastoma.
about
Gamma-enolase: a well-known tumour marker, with a less-known role in cancerPrognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyondPrognosis Research Strategy (PROGRESS) 2: prognostic factor researchHuman Tissue and ‘the Public’: The Case of Childhood Cancer Tumour BankingReporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605.Expression of neuron-specific enolase in multiple myeloma and implications for clinical diagnosis and treatmentMyc proteins as therapeutic targets.Akt2 regulates metastatic potential in neuroblastoma.Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors.Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol).P53 abnormalities and outcomes in colorectal cancer: a systematic review.Functional genomics identifies therapeutic targets for MYC-driven cancer.Can Archival Tissue Reveal Answers to Modern Research Questions?: Computer-Aided Histological Assessment of Neuroblastoma Tumours Collected over 60 YearsEvaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers.Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma.REporting recommendations for tumour MARKer prognostic studies (REMARK)Involvement of GTA protein NC2beta in neuroblastoma pathogenesis suggests that it physiologically participates in the regulation of cell proliferationExploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma.Assessment of the extent of unpublished studies in prognostic factor research: a systematic review of p53 immunohistochemistry in bladder cancer as an exampleType III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma.Midkine: a novel prognostic biomarker for cancer.ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma.EMP3 as a candidate tumor suppressor gene for solid tumors.Systems biology and modeling in neuroblastoma: practicalities and perspectives.Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma.G-quadruplexes as potential therapeutic targets for embryonal tumors.Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors.FX11 inhibits aerobic glycolysis and growth of neuroblastoma cells.The growth inhibitory effect of 17-DMAG on ALK and MYCN double-positive neuroblastoma cell line.RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma.Heterogeneity of MYCN amplification in neuroblastoma at diagnosis, treatment, relapse, and metastasis.Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells.Towards a new era of tissue-based diagnosis and research.Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.Dielectrophoretic capture and genetic analysis of single neuroblastoma tumor cells.Individualized risk assessment in neuroblastoma: does the tumoral metabolic activity on 123I-MIBG SPECT predict the outcome?The neuroblastoma and ganglion components of nodular ganglioneuroblastoma are genetically similar: evidence against separate clonal origins.Case of clear cell sarcoma in the left buttock in which serum neuron-specific enolase was a useful marker for monitoring disease progression.
P2860
Q26781703-1E6BDBCC-9C3D-4B3C-B7AE-1823D1E62CD3Q28388487-7881D7CD-0D6D-4B0C-BBFF-1C007CE43553Q28709212-9356300C-2A89-4901-9B28-844AD915FD0FQ28816171-B7B9B191-0765-4E2E-9F9A-E8A2AE65453BQ30514241-C5176E20-B9B5-4AB0-8F56-D614C0C7051AQ33500359-513DE327-1222-47EA-994B-4E7304A8906DQ33567612-4CFA9077-4F43-4062-9B00-B37CF79DC9F7Q33997741-25A43FEE-D43A-48C0-9CAA-A1E4AEADCF8AQ34611459-F96C7C51-D81B-4F71-ABA2-2B2C81C59822Q35719602-3E83FCB5-2066-40D6-B7B3-C5357F065759Q35958125-1DA0A85D-BAE9-4349-B5CA-E010ADCCBF38Q36019346-981E21A8-48E6-4DCB-87C4-947E00ACF11DQ36066213-39C66DDA-12F0-47E5-A84C-BEF48B81A8C2Q36125822-3480C151-AD61-49DC-B390-B277446A442EQ36413487-0E4650A5-5CD4-4761-A0F2-9251A85D3DDBQ36614690-C02C1EAD-E973-42EB-B5DD-97985EDAB96BQ36615178-876B70AF-264C-4114-B75D-704FC64F5B21Q36743405-C39E2589-BDB3-4FBF-A4CA-DB60AA5C8DA3Q37162188-8D55002F-7472-4974-BEAA-8730D732B249Q37236560-DABF3588-9960-47B3-8478-BC9798B7BF7DQ37259264-D2F74ABD-54B3-4050-BAEA-8E6658B2FA22Q37328317-07CAC2C3-7165-444D-9AA9-97B2FA4ADB0CQ37405597-435C8984-B777-429F-91EE-6BF1F3811E4EQ37494668-A9AFA997-5AA2-4C98-9C79-6212EE4D5095Q37705428-C50983C3-2CE3-4CBA-ADB3-0DBF8D1B8715Q37939996-EA562421-3878-424D-99A2-931A4584C72AQ38154988-EF29849D-6F49-44B5-83B0-505283E6ABAFQ38702196-2A5FDBBF-DF38-46E0-9C40-90B8964F9622Q38727558-5F5DE607-A8D2-4EC8-8221-1663E17636C5Q39051444-2CBF8E6F-D65B-4500-90A6-D81259FCF5B4Q39126205-48806769-6619-426C-AD5C-7FA9BD5481E1Q39552426-D262F2B7-6AF3-4ECE-8AA2-8A1D398C8CEEQ40026540-BA6A5AC9-1302-4B6E-BB5C-10CDD20E293AQ40143631-FE61F263-337F-4696-AA67-4A78AB5848CAQ41465370-DCD01115-DABA-44BE-A9E1-0B64E2A374D7Q42097486-1E0707A4-2AF6-459B-A308-D49C11C279BBQ48238960-D18281A5-551D-4157-88BD-0C9D5BF00E4BQ53030381-3F29ECB1-134B-4FCF-97C9-36A8CFE958BFQ54169240-2F392E23-1B04-4BE3-A64F-7D94C144CE4F
P2860
A systematic review of molecular and biological tumor markers in neuroblastoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A systematic review of molecular and biological tumor markers in neuroblastoma.
@ast
A systematic review of molecular and biological tumor markers in neuroblastoma.
@en
type
label
A systematic review of molecular and biological tumor markers in neuroblastoma.
@ast
A systematic review of molecular and biological tumor markers in neuroblastoma.
@en
prefLabel
A systematic review of molecular and biological tumor markers in neuroblastoma.
@ast
A systematic review of molecular and biological tumor markers in neuroblastoma.
@en
P2093
P50
P1476
A systematic review of molecular and biological tumor markers in neuroblastoma.
@en
P2093
Alan J Wailoo
Alex J Sutton
David Heney
David R Jones
Richard D Riley
Susan A Burchill
P356
10.1158/1078-0432.CCR-1051-2
P407
P433
P577
2004-01-01T00:00:00Z